C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2001
11/29/2001	WO2001089283A1 Protein translocation into plant cells
11/29/2001	WO2001089281A2 Tumor-associated antigen (b132), characterized by seq. id. no. 2
11/29/2001	WO2001062284A3 Novel method for down-regulation of amyloid
11/29/2001	WO2001060854A8 Novel members of the h+/oligopeptide transporter gene family
11/29/2001	WO2001058935A3 FACTOR VII OR VIIa-LIKE MOLECULES
11/29/2001	WO2001055173A8 Nucleic acids, proteins, and antibodies
11/29/2001	WO2001053515A8 Methods and materials relating to novel interleukin-1 receptor-like polypeptides and polynucleotides
11/29/2001	WO2001051509A3 Shc-associated protein 140 (sap-140)
11/29/2001	WO2001047954A3 NOVEL cDNAs ENCODING CATENIN-BINDING PROTEINS WITH FUNCTION IN SIGNALLING AND/OR GENE REGULATION
11/29/2001	WO2001044490A3 A NOVEL METHOD TO PRODUCE HUMAN NATURAL INTERFERON-$g(a)
11/29/2001	WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001	WO2001042445A3 USE OF RECOMBINANT PARAINFLUENZA VIRUSES (PIVs) AS VECTORS TO PROTECT AGAINST INFECTION AND DISEASE CAUSED BY PIV AND OTHER HUMAN PATHOGENS
11/29/2001	WO2001042283A3 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation
11/29/2001	WO2001040491A3 Udp-glucose:aglycon-glucosyltransferase
11/29/2001	WO2001040309A3 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
11/29/2001	WO2001040293A3 Method of modulating proapoptotic and antiapoptotic pathways in cells
11/29/2001	WO2001040278A3 Human semaphorin zsmf-16
11/29/2001	WO2001040257A3 Modified il-12 subunits and nucleic acids encoding them
11/29/2001	WO2001039793A3 Pharmaceutical compositions containing sema7a polypeptides
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2001038353A3 Human wnt gene
11/29/2001	WO2001038347A3 Peptides having antiangiogenic activity
11/29/2001	WO2001036644A3 Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
11/29/2001	WO2001035096A3 Diseases associated with altered mitochondrial function
11/29/2001	WO2001034823A3 Method for enhancing resistance in plants
11/29/2001	WO2001034806A3 Methods and compositions for screening using diphtheria toxin constructs
11/29/2001	WO2001032886A3 Starch branching enzymes
11/29/2001	WO2001031007A3 Nucleic acid molecules derived from rat brain and programmed cell death models
11/29/2001	WO2001029177A3 Hiv-1 subtype d peptides
11/29/2001	WO2001029064A8 Melanoma antigens and methods of use
11/29/2001	WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
11/29/2001	WO2001023560A3 Isolated peptides which bind to mhc class ii molecules, and uses thereof
11/29/2001	WO2001017550A3 Vaccine against hbv and hpv
11/29/2001	WO2001016318A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/29/2001	WO2001014546A3 Replication protein a binding transcriptional factor (rbt1) and uses thereof
11/29/2001	WO2001000864A3 Nucleic acid binding of multi-zinc finger transcription factors
11/29/2001	WO2001000826A3 Novel molecules of the card-related protein family and uses thereof
11/29/2001	WO2000064919A9 Compositions, methods, and kits relating to the tig-1 gene, a novel tzd inducible gene
11/29/2001	WO2000053229A3 Protein conjugates on the basis of lumazine synthase, methods for producing them and the use thereof
11/29/2001	WO2000048633A9 Antibodies against hydrophobic proteins that are protective against candidiasis
11/29/2001	WO2000041548A3 Methods for glucagon suppression
11/29/2001	WO2000040722A3 Insulin-synthesis genes
11/29/2001	WO2000034310A9 Purified and isolated serine-threonine kinase receptors associated protein
11/29/2001	US20010047526 Mapping molecular interactions in plants with protein fragments complementation assays
11/29/2001	US20010047522 Disease resistance in vitis
11/29/2001	US20010047521 Maize Rar1 polynucleotides and methods of use
11/29/2001	US20010047519 Polynucleotide encoding a soluble marker protein functionally linked to a regulatory sequence of an endogenous gene encoding E-selectin; drug screening
11/29/2001	US20010047091 DNA tagging with promoterless beta-glucuronidase gene generated transgenic Nicotiana tabacum plant that expressed gene activity either only in developing seed coats, or constitutively
11/29/2001	US20010047090 VANILREP1 polynucleotides and VANILREP1 polypeptides
11/29/2001	US20010047085 Adding to the protein solution a cyclodextrin in an amount sufficient to form a stable complex with the protein, lyophilizing, recovering lyophilized protein/cyclodextrin complex, heating complex to inactivate viruses
11/29/2001	US20010047084 Extendin derivatives
11/29/2001	US20010047083 Produced by hybridoma cell line ATCC No. HB12003 and progeny thereof; used in detection or treatment of carcinoembryonic antigen associated tumors
11/29/2001	US20010047082 Soluble keratin peptide
11/29/2001	US20010047081 Adenoviral capsid containing chimeric protein IX
11/29/2001	US20010047080 Inhibits hiv infection of cells
11/29/2001	US20010047077 Nucleic acid analogs with a chelating functionality
11/29/2001	US20010046976 Antimicrobial histone h1 compositions, kits, and methods of use thereof
11/29/2001	US20010046965 Making them safer for the large-scale production of adenovirus stock for use in human gene therapy trials.
11/29/2001	US20010046960 N-(2,2,2-trifluoroethyl)glycine derivatives; can be used to prepare lipophilic proteins adapted for crossing the blood brain barrier
11/29/2001	US20010046668 Binding an anchor to a substrate with a fluorescent radical attached; virus detection
11/29/2001	US20010046512 An antibody capable of specifically inhibiting the fusion of an HIV-1 envelope glycoprotein cell with a CD4+ cell without cross reacting with the HIV-1 envelope glycoprotein or CD4 and inhibits infection by strains of HIV-1
11/29/2001	US20010046505 An implantable medical device comprising a polyarylate, polymerized as a random block copolymer of a dicarboxylic acid with both tyrosine-derived diphenol and poly (alkylene oxide) in a specific ratio; used for drug delivery
11/29/2001	US20010046499 Tick antigens and compositions and methods comprising them
11/29/2001	US20010046495 Use of cross-linked, covalently bound urokinase plasminogen activator (scuPAR)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent
11/29/2001	US20010046490 Cell surface molecule-induced macrophage activation
11/29/2001	US20010045465 Bar code scanner with collimated scan volume
11/29/2001	DE10102823A1 Verfahren zur fermentativen Herstellung von L-Threonin A process for the fermentative preparation of L-threonine
11/29/2001	CA2808215A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001	CA2412306A1 Human sodium channel scn12a and scn8a
11/29/2001	CA2410566A1 Intraflagellar transport
11/29/2001	CA2410525A1 Fas ligand-fused proteins
11/29/2001	CA2410394A1 Orthologues of human receptors and methods of use
11/29/2001	CA2410337A1 Co-expression of recombinant proteins
11/29/2001	CA2410101A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2410094A1 Compositions and methods for modulating tumor specific expression
11/29/2001	CA2410083A1 Mammalian receptor proteins; related reagents and methods
11/29/2001	CA2410082A1 Dnax toll-like receptor 7 (dtlr7) protein, related reagents and methods
11/29/2001	CA2409978A1 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
11/29/2001	CA2409956A1 Use of ciliary neurotrophic factor
11/29/2001	CA2409949A1 Short-root gene, promoter, and uses thereof
11/29/2001	CA2409874A1 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
11/29/2001	CA2409873A1 Hcv variants
11/29/2001	CA2409868A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	CA2409772A1 Antiviral therapy
11/29/2001	CA2409592A1 Pharmceutical compositions comprising vip-related peptides for the treatment of sexual disorders
11/29/2001	CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001	CA2409236A1 Protein translocation into plant cells
11/29/2001	CA2408925A1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
11/29/2001	CA2408743A1 Method of detecting inflammatory lung disorders
11/29/2001	CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001	CA2408387A1 A ligand for enhancing oral and cns delivery of biological agents
11/29/2001	CA2408302A1 Long wavelength engineered fluorescent proteins
11/29/2001	CA2408141A1 Neurotransmitter transporters
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2408125A1 Synthetic peptides and uses therefore
11/29/2001	CA2408022A1 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof
11/29/2001	CA2407872A1 Receptor-based interaction trap
11/29/2001	CA2407570A1 Compositions and methods for delivery of a molecule into a cell
11/29/2001	CA2407545A1 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof

1 ... 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 ... 2916